Technical Analysis for NVO - Novo Nordisk A/S
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
52.08 | -0.29% | -0.15 |
NVO closed up 1.52 percent on Tuesday, March 19, 2019, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| See historical NVO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Mar 19 | New 52 Week Closing High | Bullish | -0.29% |
| Mar 19 | Pocket Pivot | Bullish Swing Setup | -0.29% |
| Mar 19 | New 52 Week High | Strength | -0.29% |
| Mar 19 | Upper Bollinger Band Walk | Strength | -0.29% |
| Mar 19 | BB Squeeze Ended | Range Expansion | -0.29% |
| Mar 19 | Above Upper BB | Strength | -0.29% |
| Mar 19 | Gapped Up | Strength | -0.29% |
| Mar 19 | Overbought Stochastic | Strength | -0.29% |
| Mar 19 | Up 3 Days in a Row | Strength | -0.29% |
| Mar 19 | Up 4 Days in a Row | Strength | -0.29% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2019-02-07
- Sector: Healthcare
- Industry: Pharmaceuticals
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Life Sciences Diabetes Pharmaceutical Products Inflammation Endocrine System Obesity Hormones Insulin Peptide Hormones Biopharmaceuticals Diabetes Care Glucagon Like Peptide 1 Anti Diabetic Drugs Hormone Therapy
Life Sciences Diabetes Pharmaceutical Products Inflammation Endocrine System Obesity Hormones Insulin Peptide Hormones Biopharmaceuticals Diabetes Care Glucagon Like Peptide 1 Anti Diabetic Drugs Hormone Therapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more NVO news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 52.33 |
| 52 Week Low | 41.23 |
| Average Volume | 1,342,341 |
| 200-Day Moving Average | 47.0941 |
| 50-Day Moving Average | 48.825 |
| 20-Day Moving Average | 49.862 |
| 10-Day Moving Average | 50.274 |
| Average True Range | 0.6142 |
| ADX | 24.94 |
| +DI | 44.1009 |
| -DI | 13.8012 |
| Chandelier Exit (Long, 3 ATRs ) | 50.4874 |
| Chandelier Exit (Short, 3 ATRs ) | 50.4426 |
| Upper Bollinger Band | 51.4935 |
| Lower Bollinger Band | 48.2305 |
| Percent B (%b) | 1.23 |
| BandWidth | 6.544062 |
| MACD Line | 0.7038 |
| MACD Signal Line | 0.5106 |
| MACD Histogram | 0.1932 |
| Fundamentals | Value |
|---|---|
| Market Cap | 129.54 Billion |
| Num Shares | 2.48 Billion |
| EPS | 2.49 |
| Price-to-Earnings (P/E) Ratio | 20.98 |
| Price-to-Sales | 6.57 |
| Price-to-Book | 15.49 |
| PEG Ratio | 2.42 |
| Dividend | 0.95 |
| Dividend Yield | 1.82% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 52.95 | ||||
| Resistance 3 (R3) | 52.90 | 52.62 | 52.83 | ||
| Resistance 2 (R2) | 52.62 | 52.43 | 52.64 | 52.79 | |
| Resistance 1 (R1) | 52.42 | 52.32 | 52.52 | 52.47 | 52.75 |
| Pivot Point | 52.14 | 52.14 | 52.19 | 52.16 | 52.14 |
| Support 1 (S1) | 51.94 | 51.95 | 52.04 | 51.99 | 51.71 |
| Support 2 (S2) | 51.66 | 51.84 | 51.68 | 51.67 | |
| Support 3 (S3) | 51.46 | 51.66 | 51.63 | ||
| Support 4 (S4) | 51.51 |
